Is Balamuthia mandrillaris a public health concern worldwide?

Trends in Parasitology

Volumn 29, Issue 10, 2013, Pages 483-488

  Lorenzo Morales, Jacob ^a   Cabello Vílchez, Alfonso Martín ^a,b   Martín Navarro, Carmen Ma ^a,c   Martínez Carretero, Enrique ^a   Piñero, José E ^a   Valladares, Basilio ^a  

^a UNIVERSIDAD DE LA LAGUNA   (Spain)

^b INSTITUTO DE MEDICINA TROPICAL ALEXANDER VON HUMBOLDT   (Peru)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Balamuthia mandrillaris; Emerging pathogen; Encephalitis; Skin

Indexed keywords

ALBENDAZOLE; AMPHOTERICIN B LIPID COMPLEX; AZITHROMYCIN; CLARITHROMYCIN; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; MILTEFOSINE; PENTAMIDINE ISETHIONATE; SULFADIAZINE; THIORIDAZINE;

ACANTHAMOEBA; AMOEBA (LIFE CYCLE STAGE); BALAMUTHIA INFECTION; BALAMUTHIA MANDRILLARIS; CLINICAL FEATURE; DISEASE PREDISPOSITION; HUMAN; IMMUNOCOMPROMISED PATIENT; NONHUMAN; PATHOGENESIS; REVIEW; SKIN DEFECT;

BALAMUTHIA; BALAMUTHIA MANDRILLARIS;

EID: 84884418523     PISSN: 14714922     EISSN: 14715007     Source Type: Journal    
DOI: 10.1016/j.pt.2013.07.009     Document Type: Review

References (76)

1. Visvesvara G.S., et al. Leptomyxid ameba, a new agent of amebic meningoencephalitis in humans and animals. J. Clin. Microbiol. 1990, 28:2750-2756.
2. Visvesvara G.S., et al. Balamuthia mandrillaris, N.G., N. Sp., agent of amebic meningoencephalitis in humans and other animals. J. Eukaryot. Microbiol. 1993, 40:504-514.
3. Amaral Zettler L.A., et al. A molecular reassessment of the Leptomyxid amoebae. Protist 2000, 151:275-282.
4. Booton G.C., et al. Genotyping of Balamuthia mandrillaris based on nuclear 18S and mitochondrial 16S rRNA genes. Am. J. Trop. Med. Hyg. 2003, 68:65-69.
5. Maciver S.K. The threat from Balamuthia mandrillaris. J. Med. Microbiol. 2007, 56:1-3.
6. Siddiqui R., Khan N.A. Balamuthia amoebic encephalitis: an emerging disease with fatal consequences. Microb. Pathog. 2008, 44:89-97.
7. Matin A., et al. Increasing importance of Balamuthia mandrillaris. Clin. Microbiol. Rev. 2008, 21:435-448.
8. Bravo F.G., Seas C. Balamuthia mandrillaris amoebic encephalitis: an emerging parasitic infection. Curr. Infect. Dis. Rep. 2012, 14:391-396.
9. Schuster F.L., et al. Under the radar: Balamuthia amebic encephalitis. Clin. Infect. Dis. 2009, 48:879-887.
10. Bravo F.G., et al. Balamuthia mandrillaris infection of the skin and central nervous system: an emerging disease of concern to many specialties in medicine. Curr. Opin. Infect. Dis. 2011, 24:112-117.
11. Krasaelap A., et al. Fatal Balamuthia amebic encephalitis in a healthy child: a case report with review of survival cases. Korean J. Parasitol. 2013, 51:335-341.
12. Diaz J.H. The public health threat from Balamuthia mandrillaris in the southern United States. J. La. State Med. Soc. 2011, 163:197-204.
13. Riestra-Castaneda J.M., et al. Granulomatous amebic encephalitis due to Balamuthia mandrillaris (Leptomyxiidae): report of four cases from Mexico. Am. J. Trop. Med. Hyg. 1997, 56:603-607.
14. Bravo F.G., et al. Cutaneous manifestations of infection by free living amebas, with special emphasis on Balamuthia mandrillaris. Tropical Dermatology 2005, 49-56. Churchill Livingstone. S.K. Tyring (Ed.).
15. Rodríguez R., et al. Central nervous system infection by free-living amebas: report of 3 Venezuelan cases. Rev. Neurol. 1998, 26:1005-1008.
16. Galarza M., et al. Pediatric granulomatous cerebral amebiasis: a delayed diagnosis. Pediatr. Neurol. 2002, 26:153-156.
17. Silva R.A., et al. Granulomatous amoebic meningoencephalitis in an immunocompetent patient. Arch. Neurol. 2010, 67:1516-1520.
18. Silva-Vergara M.L., et al. Disseminated Balamuthia mandrillaris amoeba infection in an AIDS patient from Brazil. Am. J. Trop. Med. Hyg. 2007, 77:1096-1109.
19. Oddó B.D., et al. Granulomatous amebic encephalitis caused by Balamuthia mandrillaris. First case diagnosed in Chile. Rev. Chilena Infectol. 2006, 23:232-236.
20. Prasad K., et al. Fatal subacute necrotising brainstem encephalitis in a young man due to a rare parasitic (Balamuthia) infection. Pract. Neurol. 2008, 8:112-117.
21. Bando Y., et al. Autopsy case of amebic granulomatous meningoencephalitis caused by Balamuthia mandrillaris in Japan. Pathol. Int. 2012, 62:418-423.
22. Yamasaki K., et al. Granulomatous amoebic encephalitis caused by Balamuthia mandrillaris. Neurol. Med. Chir. (Tokyo) 2011, 51:667-670.
23. Intalapaporn P., et al. Balamuthia mandrillaris meningoencephalitis: the first case in southeast Asia. Am. J. Trop. Med. Hyg. 2004, 70:666-669.
24. Doyle J.S., et al. Balamuthia mandrillaris brain abscess successfully treated with complete surgical excision and prolonged combination antimicrobial therapy. J. Neurosurg. 2011, 114:458-462.
25. Hill C.P., et al. Balamuthia amebic meningoencephalitis and mycotic aneurysms in an infant. Pediatr. Neurol. 2011, 45:45-48. 10.1016/jpedriatrneurol2011.05.003.
26. Jayasekera S., et al. Post-mortem culture of Balamuthia mandrillaris from the brain and cerebrospinal fluid of a case of granulomatous amoebic meningoencephalitis, using human brain microvascular endothelial cells. J. Med. Microbiol. 2004, 53:1007-1012.
27. Tavares M., et al. Diagnosis of first case of Balamuthia amoebic encephalitis in Portugal by immunofluorescence and PCR. J. Clin. Microbiol. 2006, 44:2660-2663.
28. Kodet R., et al. Amebic encephalitis caused by Balamuthia mandrillaris in a Czech child: description of the first case from Europe. Pathol. Res. Pract. 1998, 194:423-429.
29. Moser M.A. A descriptive review of Balamuthia and non-keratitis Acanthamoeba cases in the United States, 1955-2009. Public Health Theses 2011, Paper 162.
30. Centers for Disease Control, Prevention Balamuthia amebic encephalitis - California 1999-2007. MMWR Morb. Mortal. Wkly. Rep. 2008, 57:768-771.
31. Cuevas P.M., et al. Granulomatous amoebic meningoencephalitis by Balamuthia mandrillaris: case report and literature review. Rev. Chilena Infectol. 2006, 23:237-242.
32. Kiderlen A.F., et al. Balamuthia and Acanthamoeba-binding antibodies in West African human sera. Exp. Parasitol. 2010, 126:28-32.
33. Schuster F.L., et al. Balamuthia mandrillaris, agent of amebic encephalitis: detection of serum antibodies and antigenic similarity of isolates by enzyme immunoassay. J. Eukaryot. Microbiol. 2008, 55:313-320.
34. Botterill E., Yip G. A rare survivor of Balamuthia granulomatous encephalitis. Clin. Neurol. Neurosurg. 2011, 113:499-502.
35. Schuster F.L., et al. Balamuthia amebic encephalitis risk, Hispanic Americans. Emerg. Infect. Dis. 2004, 10:1510-1512.
36. Centers for Disease Control, Prevention (CDC) Notes from the field: transplant-transmitted Balamuthia mandrillaris - Arizona, 2010. MMWR Morb. Mortal. Wkly. Rep. 2010, 59:1182.
37. Schuster F.L., et al. Environmental isolation of Balamuthia mandrillaris associated with a case of amebic encephalitis. J. Clin. Microbiol. 2003, 41:3175-3180.
38. Dunnebacke T.H., et al. Balamuthia mandrillaris from soil samples. Microbiology 2004, 150:2837-2842.
39. Centers for Disease Control, Prevention (CDC) Balamuthia mandrillaris transmitted through organ transplantation - Mississippi, 2009. MMWR Morb. Mortal. Wkly. Rep. 2009, 59:1165-1170.
40. Finnin P.J., et al. Multifocal Balamuthia mandrillaris infection in a dog in Australia. Parasitol. Res. 2007, 100:423-426.
41. Foreman O., et al. Disseminated infection with Balamuthia mandrillaris in a dog. Vet. Pathol. 2004, 41:506-510.
42. Hodge P.J., et al. Another case of canine amoebic meningoencephalitis - the challenges of reaching a rapid diagnosis. Parasitol. Res. 2011, 108:1069-1073.
43. Kinde H., et al. Infections caused by pathogenic free-living amebas (Balamuthia mandrillaris and Acanthamoeba sp.) in horses. J. Vet. Diagn. Invest. 2007, 19:317-322.
44. Rideout B.A., et al. Fatal infections with Balamuthia mandrillaris (a free-living amoeba) in gorillas and other Old World primates. Vet. Pathol. 1997, 34:15-22.
45. Mätz-Rensing K., et al. Fatal Balamuthia mandrillaris infection in a gorilla - first case of balamuthiasis in Germany. J. Med. Primatol. 2011, 40:437-440.
46. Schuster F.L., Visvesvara G.S. Free-living amoebae as opportunistic and non-opportunistic pathogens of humans and animals. Int. J. Parasitol. 2004, 34:1001-1027.
47. Niyyati M., et al. Isolation of Balamuthia mandrillaris from urban dust, free of known infectious involvement. Parasitol. Res. 2009, 106:279-281.
48. Ahmad A.F., et al. Development of a nested PCR for environmental detection of the pathogenic free-living amoeba Balamuthia mandrillaris. J. Eukaryot. Microbiol. 2011, 58:269-271.
49. Visvesvara G.S., et al. Pathogenic and opportunistic free living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea. FEMS Immunol. Med. Microbiol. 2007, 50:1-26.
50. Schuster F.L., et al. Axenic growth and drug sensitivity studies of Balamuthia mandrillaris, an agent of amebic meningoencephalitis in human and other animals. J. Clin. Microbiol. 1996, 34:385-388.
51. Dunnebacke T.H. Balamuthia mandrillaris: the multiple nuclei of Balamuthia amebas; their location, activity, and site of development. Exp. Parasitol. 2010, 126:14-21.
52. Matin A., et al. Balamuthia mandrillaris interactions with human brain microvascular endothelial cells in vitro. J. Med. Microbiol. 2007, 56:1110-1115.
53. Tapia J.L., et al. Balamuthia mandrillaris: in vitro interactions with selected protozoa and algae. J. Eukaryot. Microbiol. 2013, 10.1111/jeu.12052.
54. Siddiqui R., et al. Killing the dead: chemotherapeutic strategies against free-living cyst-forming protists (Acanthamoeba sp. and Balamuthia mandrillaris). J. Eukaryot. Microbiol. 2013, 60:291-297.
55. Siddiqui R., et al. The cyst wall carbohydrate composition of Balamuthia mandrillaris. Parasitol. Res. 2009, 104:1439-1443.
56. Siddiqui R., et al. Balamuthia mandrillaris resistance to hostile conditions. J. Med. Microbiol. 2008, 57:428-431.
57. Siddiqui R., et al. Balamuthia mandrillaris: role of galactose in encystment and identification of potential inhibitory targets. Exp. Parasitol. 2010, 126:22-27.
58. Kiderlen A.F., Laube U Balamuthia mandrillaris, an opportunistic agent of granulomatous amebic encephalitis, infects the brain via the olfactory nerve pathway. Parasitol. Res. 2004, 94:49-52.
59. Combs F.J., et al. Best cases from the AFIP: Balamuthia mandrillaris amebic meningoencephalitis. Radiographics 2011, 31:31-35.
60. Kiderlen A.F., et al. Detection of Balamuthia mandrillaris DNA by real-time PCR targeting the RNase P gene. BMC Microbiol. 2008, 8:210.
61. Guarner J., et al. Histopathologic spectrum and immunohistochemical diagnosis of amebic meningoencephalitis. Mod. Pathol. 2007, 20:1230-1237.
62. Kucerova Z., et al. Identification of antigenic targets for immunodetection of Balamuthia mandrillaris infection. Clin. Vaccine Immunol. 2011, 18:1297-1301.
63. Huang Z.H., et al. Serum antibodies to Balamuthia mandrillaris, a free-living amoeba recently demonstrated to cause granulomatous amoebic encephalitis. J. Infect. Dis. 1999, 179:1305-1308.
64. Yagi S., et al. Detection of Balamuthia mitochondrial 16S rRNA gene DNA in clinical specimens by PCR. J. Clin. Microbiol. 2005, 43:3192-3197.
65. Qvarnstrom Y., et al. Multiplex real-time PCR assay for simultaneous detection of Acanthamoeba spp., Balamuthia mandrillaris, and Naegleria fowleri. J. Clin. Microbiol. 2006, 44:3589-3595.
66. Schuster F.L., et al. In-vitro activity of miltefosine and voriconazole on clinical isolates of free-living amebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri. J. Eukaryot. Microbiol. 2006, 53:121-126.
67. Lemke A., et al. Delivery of amphotericin B nanosuspensions to the brain and determination of activity against Balamuthia mandrillaris amebas. Nanomedicine 2010, 6:597-603.
68. Deetz T.R., et al. Successful treatment of Balamuthia amoebic encephalitis: presentation of 2 cases. Clin. Infect. Dis. 2003, 37:1304-1312.
69. Orozco L., et al. Neurosurgical intervention in the diagnosis and treatment of Balamuthia mandrillaris encephalitis. J. Neurosurg. 2011, 115:636-640.
70. Jung S., et al. Balamuthia mandrillaris meningoencephalitis in an immunocompetent patient. an unusual clinical course and a favorable outcome. Arch. Pathol. Lab. Med. 2004, 128:466-468.
71. Martínez D.Y. Successful treatment of Balamuthia mandrillaris amoebic infection with extensive neurological and cutaneous involvement. Clin. Infect. Dis. 2010, 51:7-11.
72. Cary L.C., et al. Balamuthia mandrillaris meningoencephalitis: survival of a pediatric patient. Pediatrics 2010, 125:699-703.
73. Lorenzo-Morales J., et al. Acanthamoeba keratitis: an emerging disease gathering importance worldwide?. Trends Parasitol. 2013, 29:181-187.
74. Martín-Navarro, et al. Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and application of statins as a novel effective therapeutic approach against Acanthamoeba infections. Antimicrob. Agents Chemother. 2013, 57:375-381.
75. Lorenzo-Morales J., et al. Therapeutic potential of a combination of two gene-specific small interfering RNAs against clinical strains of Acanthamoeba. Antimicrob. Agents Chemother. 2010, 54:5151-5155.
76. Kiderlen A.F., et al. Assessment of Balamuthia mandrillaris-specific serum antibody concentrations by flow cytometry. Parasitol. Res. 2009, 104:663-670.